Ligand id: 1135

Name: exendin-4

1. Bond A. (2006)
Exenatide (Byetta) as a novel treatment option for type 2 diabetes mellitus.
Proc (Bayl Univ Med Cent), 19 (3): 281-4. [PMID:17252050]
2. Jorgensen R, Martini L, Schwartz TW, Elling CE. (2005)
Characterization of glucagon-like peptide-1 receptor beta-arrestin 2 interaction: a high-affinity receptor phenotype.
Mol Endocrinol, 19: 812-823. [PMID:15528268]
3. Miranda LP, Winters KA, Gegg CV, Patel A, Aral J, Long J, Zhang J, Diamond S, Guido M, Stanislaus S et al.. (2008)
Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity.
J. Med. Chem., 51 (9): 2758-65. [PMID:18412318]